# Theranova Randomized, Controlled, Trial (RCT) in China

> **NCT05309291** · NA · COMPLETED · sponsor: **Vantive Health LLC** · enrollment: 323 (actual)

## Conditions studied

- Chronic Kidney Failure
- Acute Kidney Failure

## Interventions

- **DEVICE:** Theranova 400 Dialyzer
- **DEVICE:** FX 800 Dialyzer

## Key facts

- **NCT ID:** NCT05309291
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-22
- **Primary completion:** 2023-07-06
- **Final completion:** 2023-07-06
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2025-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05309291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05309291, "Theranova Randomized, Controlled, Trial (RCT) in China". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05309291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*